Chapter 1: Understanding Cryonics

Tomorrow.bio stores its patients at the European Biostasis Foundation's underground facility in Switzerland. This facility was specially designed for long-term stability and security. Switzerland was chosen due to its security, socio-economic stability, strict oversight of non-profits, and low risk of natural disasters.

‍

Why Switzerland?

Security & stability

Switzerland is Europe’s most stable country, politically, financially, and socially. It’s extremely safe, with no natural disasters, making it the perfect location for a long-term cryonics storage facility, ensuring security and reliability for preservation.

Mission integrity

Operating as a non-profit in Switzerland means that any changes to the mission of an organization are incredibly difficult, if not impossible. This legal framework ensures that EBF remains committed to its purpose, providing long-term security for its goals.

Environmental security

Geographically, Switzerland is one of the safest countries in the world, with minimal risk of natural disasters. This contributes to the country's stability, ensuring a secure environment.

‍

What is a long-term storage facility used for?

As the name would suggest, the main purpose of these facilities is to store cryopreserved patients for an indefinite period of time. In the case of cryonics, we’re talking about human bodies (or brains) that are stored inside specialized cryogenic dewars. Either fully submerged in liquid nitrogen at -196°C or in the vapor phase ( (ITS-systems), at 140°C) with the goal to fully preserve their cell-structures until future revival is possible.

To get to this point, patients first have to go through the initial stages of the cryoprotection process after legal death. For this, their bodies are cooled down and perfused with cryoprotectants.

Once the patient’s body temperature has been sufficiently cooled and perfusion is complete, they are be transported to the long-term storage facility. These are usually built in areas with very little to no risk of natural catastrophes and legal environments that are beneficial to human cryopreservation. Prolonged safety is of utmost importance. Tomorrow.bio’s patients are stored at the European Biostasis Foundation’s facility in Rafz, Switzerland.

From the outside, a cryonics long-term storage facility might not look much different from a regular warehouse (with some unusual ventilation system), and it doesn’t need to. What makes one such facility special is the extra safety precautions and the contents found inside.

‍

‍